A Phase I Trial of Palbociclib in Combination With Dexamethasone in Relapsed or Refractory Adult B-Cell Acute Lymphoblastic Leukemia (ALL)
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2019
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary) ; Palbociclib (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 04 Jun 2019 The patients are currently enrolling in the cohort 1 of the study. Once a maximum tolerated dose is established, an expansion cohort is planned, trial design presented at the 55th Annual Meeting of the American Society of Clinical Oncology.
- 04 Jun 2019 Trial design presented at the 55th Annual Meeting of the American Society of Clinical Oncology.
- 23 May 2018 Status changed from not yet recruiting to recruiting.